READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION FASENRA® and FASENRA PEN™ benralizumab i
CURED foundation | AstraZeneca announced FASENRA has been approved by the FDA for patients aged 6 to 11 years old living with severe eosinophilic asthma in ... | Instagram
![These highlights do not include all the information needed to use FASENRA® safely and effectively. See full prescribing information for FASENRA.FASENRA (benralizumab) injection, for subcutaneous useInitial U.S. Approval: 2017 These highlights do not include all the information needed to use FASENRA® safely and effectively. See full prescribing information for FASENRA.FASENRA (benralizumab) injection, for subcutaneous useInitial U.S. Approval: 2017](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=step_7_a_position_the_pen_at_the_injection_site.jpg&id=732321)